Boehringer Ingelheim Acquires Abexxa Biologics, Expanding Cancer Treatment Potential September 23, 2021 Auto Bot News 0 Boehringer Ingelheim to develop novel cancer therapies by leveraging Abexxa’s breakthrough antibody-based drugs.